Shares of Walgreens Boots Alliance Inc. WBA slipped 2.59% to $10.51 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.43% to 6,117.52 and Dow Jones Industrial Average DJIA falling 1.01% to 44,176.65.

Walgreens Boots Alliance (WBA) stock is advancing nearly 12% after CNBC reported that the troubled pharmacy chain could still be acquired. WBA May Be Bought After All After reporting on Jan 27 that a possible acquisition of WBA by private equity firm Sycamore Partners was “mostly dead,

Shares of Walgreens Boots Alliance (NASDAQ: WBA) were moving higher today after CNBC's David Faber said that a possible deal to take over the ailing pharmacy and urgent-care chain was still alive. Trading in the stock was also halted Tuesday morning,

As per a media report in December, Walgreens Boots Alliance Inc WBA +13.9% + Free Alerts suggested the company is in talks to be acquired by Sycamore Partners. Walgreens's market value has shrunk from over $100 billion a decade ago to around $8.4 billion, as per data from Benzinga Pro.

Walgreens-Boots Alliance struggles with margin compression, competition, and financial risks. Learn why these challenges make WBA a strong sell.

Shares of Walgreens Boots Alliance Inc. surged 14.02% to $11.06 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.24% to 6,129.

What Happened? Shares of pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) jumped 13.5% in the morning session after CNBC's David Faber said that a potential deal between the company (Walgreens) and private equity firm Sycamore Partners "was showing signs of life.